Navigation Links
Mayo Clinic hosts NIH genomics director at Individualizing Medicine Conference
Date:9/17/2013

ROCHESTER, Minn.-- From Promise to Practice is the title and the main message of the second annual Individualizing Medicine Conference at Mayo Clinic, Sept. 30-Oct. 2. Physicians from more than 40 states and several countries will be arriving in Minnesota to hear and learn about the latest developments and research in genomic research and how to move these discoveries into the medical practice.

"Our goal is to inform practicing physicians, but other care providers, students, media and the public as well," says Richard Weinshilboum, M.D., chair of this year's conference held by Mayo Clinic's Center for Individualized Medicine. "Individualizing prevention, diagnosis and treatment is the core of medical genomics and the future of medicine. Even if you missed the last 13 years since the mapping of the human genome, we'll help you catch up in three days."

Opening keynote speaker on Monday, September 30, will be Eric Green, M.D., Ph.D., director of the National Institute of Genomic Health Research, Bethesda, M.D. Co-hosts for the conference will be Richard Besser, M.D., chief health and medical editor for ABC News and former acting director of the Centers for Disease Control, and Ceci Connolly, managing director of the Health Research Institute, PwC.

The conference offers expert speakers, focused breakout sessions, and real-life case studies so participants can discover and discuss emerging topics in medical genomics. Topics range from translating genomic findings into clinical care to communicating accurately and ethically with patients. Also this year, on Sunday Sept. 29, an "Omics 101" seminar will be offered at a lay level for those new to individualized medicine. This course is being offered separately and is ideal for students and media who will be working in or reporting on the genomics field.

Individualized medicine is a growing field of patient care based on the increasing knowledge of the human genome, mapped just a decade ago. Mayo Clinic is a leader in transferring medical genomics to medical practice clinomics as evidenced by its Individualized Medicine Clinic, launched a year ago. Mayo's Center for Individualized Medicine also includes programs in biomarker discovery, pharmacogenomics, epigenomics and the human microbiome.

Individualizing Medicine 2013 is supported by the Satter Foundation.


'/>"/>

Contact: Bob Nellis
newsbureau@mayo.edu
507-284-5005
Mayo Clinic
Source:Eurekalert

Related biology news :

1. Wistar receives $1.5 million Department of Defense grant to ready prostate drug for clinical use
2. DO-HEALTH a multi-center clinical trial on healthy ageing achieves first milestone
3. Physiotherapy in Singapore Clinic Urbanrehab Pte Ltd Announces the Opening of an Additional Location
4. With early, obvious benefit of a targeted cancer drug, should expensive clinical testing continue?
5. Egg donation in European clinics: Why do women do it?
6. Damon Runyon Cancer Research Foundation awards $3.6 M to 9 top young clinical investigators
7. UCLA stem cell gene therapy for sickle cell disease advances toward clinical trials
8. New sickle cell anemia therapy advances to Phase II clinical trials
9. Inflection Biosciences licenses preclinical oncology programs from the CNIO
10. Alios BioPharma initiates Phase 1 clinical trial for respiratory syncytial virus infection
11. Center for Clinical and Translational Science awards new pilot grants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/15/2016)... , June 15, 2016 ... report titled "Gesture Recognition Market by Application Market - Global Industry ... - 2024". According to the report, the  global gesture ... in 2015 and is estimated to grow at ... billion by 2024.  Increasing application of ...
(Date:6/2/2016)... , June 2, 2016 The Department ... has awarded the 44 million US Dollar project, for the ... Vehicle Plates including Personalization, Enrolment, and IT Infrastructure , ... in the production and implementation of Identity Management Solutions. Numerous ... however Decatur was selected for the ...
(Date:5/20/2016)... 2016  VoiceIt is excited to announce its ... By working together, VoiceIt and VoicePass will ... VoicePass take slightly different approaches to voice biometrics, ... and usability. ... partnership. "This marketing and technology partnership ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... /PRNewswire/ - FACIT has announced the creation of ... company, Propellon Therapeutics Inc. ("Propellon" or "the Company"), ... portfolio of first-in-class WDR5 inhibitors for the treatment ... represent an exciting class of therapies, possessing the ... cancer patients. Substantial advances have been achieved with ...
(Date:6/23/2016)... NEW YORK , June, 23, 2016  The ... students to envision new ways to harness living systems ... of Modern Art (MoMA) in New York ... more than 130 participating students, showcased projects at MoMA,s ... included Paola Antonelli , MoMA,s senior curator of ...
(Date:6/23/2016)... 23, 2016 Apellis Pharmaceuticals, Inc. today ... trials of its complement C3 inhibitor, APL-2. The ... ascending dose studies designed to assess the safety, ... injection in healthy adult volunteers. Forty ... a single dose (ranging from 45 to 1,440mg) ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... regulatory and technical consulting, provides a free webinar on Performing Quality ... 13, 2016 at 12pm CT at no charge. , Incomplete investigations are still ...
Breaking Biology Technology: